Labcorp Holdings Share Repurchase Program, Remaining Authorized, Amount decreased by 30.6% to $732.40M in Q1 2026 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
A high remaining balance indicates potential future support for the stock price through buybacks.
This is the portion of the board-authorized share repurchase program that has not yet been executed. It indicates the re...
Used by investors to gauge the near-term potential for share count reduction and capital return.
other_stock_repurchase_program_remaining_authorized_repu_889179| Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|
| Value | $1.08B | $1.06B | $732.40M |
| QoQ Change | — | -2.3% | -30.6% |